Development and use of specific ELISA methods for quantifying the biological activity of bevacizumab, cetuximab and trastuzumab in stability studies.
Suárez, Inmaculada
Development and use of specific ELISA methods for quantifying the biological activity of bevacizumab, cetuximab and trastuzumab in stability studies. [electronic resource] - Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Oct 2016 - 155-164 p. digital
Publication Type: Journal Article
1873-376X
10.1016/j.jchromb.2016.05.045 doi
Antineoplastic Agents--chemistry
Bevacizumab--chemistry
Cetuximab--chemistry
Drug Stability
Enzyme-Linked Immunosorbent Assay--methods
Humans
Protein Stability
Trastuzumab--chemistry
Development and use of specific ELISA methods for quantifying the biological activity of bevacizumab, cetuximab and trastuzumab in stability studies. [electronic resource] - Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Oct 2016 - 155-164 p. digital
Publication Type: Journal Article
1873-376X
10.1016/j.jchromb.2016.05.045 doi
Antineoplastic Agents--chemistry
Bevacizumab--chemistry
Cetuximab--chemistry
Drug Stability
Enzyme-Linked Immunosorbent Assay--methods
Humans
Protein Stability
Trastuzumab--chemistry